UBS Group’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.59M Sell
315,167
-162,229
-34% -$818K ﹤0.01% 4004
2025
Q1
$3.09M Buy
477,396
+237,283
+99% +$1.54M ﹤0.01% 3370
2024
Q4
$1.76M Sell
240,113
-143,075
-37% -$1.05M ﹤0.01% 3815
2024
Q3
$2.87M Buy
383,188
+89,713
+31% +$672K ﹤0.01% 2748
2024
Q2
$2.61M Sell
293,475
-172,733
-37% -$1.54M ﹤0.01% 2613
2024
Q1
$4.72M Sell
466,208
-59,972
-11% -$608K ﹤0.01% 2247
2023
Q4
$5.29M Buy
526,180
+240,648
+84% +$2.42M ﹤0.01% 1970
2023
Q3
$2.68M Buy
285,532
+74,704
+35% +$700K ﹤0.01% 2326
2023
Q2
$5.17M Buy
210,828
+88,702
+73% +$2.18M ﹤0.01% 1877
2023
Q1
$2.84M Sell
122,126
-167,601
-58% -$3.9M ﹤0.01% 2277
2022
Q4
$7.33M Buy
289,727
+185,199
+177% +$4.69M ﹤0.01% 1548
2022
Q3
$2.02M Sell
104,528
-22,347
-18% -$431K ﹤0.01% 2352
2022
Q2
$3.23M Sell
126,875
-194,178
-60% -$4.94M ﹤0.01% 2064
2022
Q1
$8.26M Buy
321,053
+225,346
+235% +$5.8M ﹤0.01% 1574
2021
Q4
$4.01M Buy
95,707
+75,375
+371% +$3.16M ﹤0.01% 2298
2021
Q3
$884K Sell
20,332
-1,459
-7% -$63.4K ﹤0.01% 3344
2021
Q2
$1.03M Sell
21,791
-13,185
-38% -$623K ﹤0.01% 3223
2021
Q1
$1.79M Sell
34,976
-10,515
-23% -$539K ﹤0.01% 2856
2020
Q4
$1.22M Sell
45,491
-19,930
-30% -$534K ﹤0.01% 3015
2020
Q3
$2.25M Buy
65,421
+27,993
+75% +$961K ﹤0.01% 2322
2020
Q2
$1.53M Buy
37,428
+33,241
+794% +$1.36M ﹤0.01% 2494
2020
Q1
$143K Sell
4,187
-7,770
-65% -$265K ﹤0.01% 4140
2019
Q4
$150K Buy
+11,957
New +$150K ﹤0.01% 4767